icon_loop icon_cart icon_arrow-down icon_pick-winners icon_make-better-decisions icon_gofaster-gosmarter icon_equio icon_custom-research icon_conquer-the-wild icon_be-anonymous-and-secure icon_analyst-reports icon_access-realtime-data icon_youtube icon_twitter icon_linkedin icon_facebook

How Final Tax Reforms Impact Your Cannabis Business

By Selvan Boominathan, JD, LLM The Tax Cuts and Jobs Act (TCJA) has become the law of the land, and yet, still no relief for cannabis businesses from Section 280E.  As we wrote in an earlier post, there are still significant tax reductions available to cannabis taxpayers, if you know where to look.  This post […]
Read more

WHO to DOJ, re: CBD: It’s All (Medicinally) Good

By J.J. McCoy, Senior Managing Editor for New Frontier Data Newly published findings from the World Health Organization (WHO) about the medicinal benefits of cannabidiol (CBD) fall in direct opposition to the stance of the U.S. federal government’s keeping it listed as a Schedule I controlled substance. Publishing recent findings which directly contradict both the established […]
Read more

DOJ Rescinds Cole Memo, Raising Stakes for Rohrabacher-Blumenauer Renewal

By J.J. McCoy, Senior Managing Editor for New Frontier Data In a three-paragraph memo released on Thursday, U.S. Attorney General Jeff Sessions rescinded several Obama-era directives which since 2013 had discouraged enforcement of federal marijuana laws in states which had legalized cannabis. Sessions encouraged federal prosecutors to use their own discretion — given the department’s limited [...]
Read more

Alaska’s New Year’s Resolution: To Decide About Onsite Consumption

By J.J. McCoy, Senior Managing Editor for New Frontier Data Were Santa to try and find some medical cannabis to help treat his lower back after completion of his Christmas rounds, a dispensary in Denali, Alaska, would be the closest location from North Pole, Alaska (2016 population: 2,232). But it would be no surprise: It was […]
Read more

Cost Segregation and Cannabis Business Owned Real Estate

By Derek Weaver, Senior Manager As discussed two weeks ago, 280E continues to be a major problem for plant-touching businesses. However, there are several opportunities to minimize taxes and maximize cash flow for ancillary businesses that serve the cannabis industry. This week we will take a look at cost segregation and the benefits for real […]
Read more

What Proposed Tax Cuts Mean for Cannabis: Only a Bill?

By Selvan Boominathan, JD, LLM In a prior post, we discussed how federal income tax applies to cannabis businesses and the huge burden imposed by Section 280E.  You may have read about the major tax cuts being proposed in Congress recently which are meant to spur economic and industrial growth across America.  Surely Congress would […]
Read more

Death, Taxes, and Cannabis: How to Keep 280E From Killing You

By Michael Harlow, CPA, Partner To quote Benjamin Franklin, “In this world nothing can be said to be certain, except death and taxes,” and people in the cannabis industry are certainly experiencing heart palpitations when it comes to the federal tax code. In a 1981 court case, a convicted drug trafficker successfully asserted his right […]
Read more

LePage’s Broken Campaign Pledge Puts the Brakes on Maine’s Adult Use Market

By J.J. McCoy, Senior Managing Editor for New Frontier Data At the start of this month, Maine Republican Governor Paul LePage vetoed the state’s pending bill to establish rules for implementation of an adult use cannabis program. In so doing, he ignored his own 2014 re-election campaign pledge, and subsequently introduced political and practical uncertainty into […]
Read more

Medical Markets Remain a Sound Investment Prescription for 2018

By New Frontier Data staff analysts Next month will mark a year since millions of Americans successfully voted to legalize the use of medical cannabis in Florida, North Dakota, and Arkansas; to reinstate the medical cannabis program in Montana; and to legalize adult use in California, Massachusetts, Nevada, and Maine. With the states of Louisiana, […]
Read more

Three Core Things for Investors to Consider About Cannabis Investments

Mitch Baruchowitz, Managing Partner at Merida Capital Partners The public market for cannabis companies is still developing, which leaves the vast majority of investment to the private market. My partners and I formed Merida Capital Partners to take advantage of our sector knowledge, and provide a vehicle for rational, institutional quality asset management in the […]
Read more